- Abstract Number: 1620
T-cell Exhaustion in Prolonged Remission SLE Patients
- Abstract Number: 748
Takayasu Arteritis and Sacroiliitis: A Case Control Study in 28 Patients of a Single Italian Center
- Abstract Number: 2740
Takayasu Arteritis Associated Risk Locus in IL6 Represses the Anti-inflammatory Gene GPNMB Through Chromatin Looping and Recruiting MEF2-HDAC Complex
- Abstract Number: 1432
Tapering and Discontinuing Prednisolone Without Deteriorated Disease Control by Optimizing Methotrexate in Patients with Rheumatoid Arthritis Under Stable Treatment – 2-year Results in the Real-world Clinical Practice –
- Abstract Number: L08
Tapering of Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs in Rheumatoid Arthritis Patients in Sustained Remission: Results from a Randomized Controlled Trial
- Abstract Number: 614
Tapering of Tumor Necrosis Factor Inhibitor and Healthcare Cost Differences in Patients with Ankylosing Spondylitis: A Retrospective Analysis of Korean National Health Insurance Data
- Abstract Number: 1702
Target Organ Associations in Polyarteritis Nodosa (PAN): Results of a Worldwide Collaboration Study
- Abstract Number: 634
Targeted 1H NMR Based Metabolomics Analysis Revealed Significantly Higher Synovial Phe/Tyr Ratio in Reactive Arthritis and Undifferentiated Spondyloarthropathy
- Abstract Number: 999
Targeted Drug Delivery Using a Novel Joint-homing Peptide for Arthritis Therapy
- Abstract Number: 2274
Targeted Education Improves Awareness of Reproductive Health Issues Among Women with Rheumatologic Diseases
- Abstract Number: 109
Targeting CD6 Expression Attenuates T Cell Activity in Murine Collagen Induced Arthritis
- Abstract Number: 100
Targeting ITK Signaling Ameliorates Collagen-Induced Arthritis via Shifting the Balance Between Th17 and Regulatory Th17 Cells
- Abstract Number: 1911
Targeting the Oxidative Stress Pathway in Experimental Spondyloarthritis Reduces Pro-inflammatory Response in Rat Macrophages and Modulates Their Metabolic Requirements
- Abstract Number: 149
Teaching Rare Diseases Through Role Play: Results of an Experimental Workshop About Raynaud Phenomenon
- Abstract Number: 2662
Temporal Artery Biopsy Lengths in Alberta: Which Surgical Subspecialty Achieves Optimal Biopsy Lengths?
- Abstract Number: 566
Temporal Relationship Between Enteropathic Spondylitis Symptoms/diagnosis and Inflammatory Bowel Diseases Diagnosis: HUR-BIO Real Life Results
- Abstract Number: 622
Ten-year Atherosclerotic Cardiovascular Disease Risk Scores in Axial Spondyloarthritis versus the General Population: A Cross-sectional Study
- Abstract Number: 1005
Tendon T-cell Interactions as Drivers of Chronicity in Spondyloarthritis
- Abstract Number: 294
Tendons Involvement at Early Onset of Gouty Arthritis, Ultrasonographic Study
- Abstract Number: 1990
Tenofovir Modulates Semaphorin 4D Signaling and Regulates Bone Homeostasis, Which Can Be Counteracted by Dipyridamole and Adenosine A2A Receptor
- Abstract Number: 1856
Tenosynovial Aspiration by Ultrasound Guidance: Correlation and Diagnostic Implications of Tenosynovial Analysis and Ultrasound Doppler Signal
- Abstract Number: 2019
Tenosynovitis at the Metatarsophalangeal Joints, a Novel Feature of RA: Results from an Anatomical and Large Magnetic Resonance Imaging Study of Tendon Sheaths of the Forefoot
- Abstract Number: 1807
Teprotumumab, a Novel Biologic for Active Thyroid Eye Disease
- Abstract Number: 2174
Test-Retest Reliability and Validity of a Mobile Health Application to Automate the 30 Seconds Chair Stand Test – Preliminary Data to Create a Contemporary Instrument for Randomized Clinical Trials
- Abstract Number: 2847
Testing Different Thresholds for Patient Global Assessment in Defining ACR-EULAR Boolean Remission Criteria for RA
- Abstract Number: 1202
Testing Rheumatoid Arthritis Performance Measures to Optimize Treat to Target Strategies
- Abstract Number: 1044
TGF-β Isoforms Modulate the RNA Cargo of Extracellular Vesicles (Exosomes) Isolated from Cultured Normal Human Lung Microvascular Endothelial Cells: A Mechanistic Link Between Endothelial Cell Dysfunction and the Establishment of a Profibrotic Phenotype in SSc?
- Abstract Number: 2506
The ‘Severity of Nail Psoriasis Score’ (SNAPS) Is Feasible, Reliable and Demonstrates Construct Validity Against the mNAPSI in an Observational Cohort of Patients with Psoriatic Arthritis
- Abstract Number: 2252
The #Worldlupusday 2019 Across Twitter: An Explorative Analysis of Spreading Concepts and Sentiment Perceptions on Social Media
- Abstract Number: 304
The ACR’s Rheumatology Informatics System for Effectiveness (RISE) Demonstrates Improvements in Many Measures of Quality of Care Between 2015 and 2017
- Abstract Number: 1819
The Ankylosing Spondylitis Disease Activity Score Reflects and Predicts Response to Biologic Treatment in Axial Spondyloarthritis Patients with Coexistent Fibromyalgia Compared to the Bath Ankylosing Spondylitis Disease Activity Index
- Abstract Number: 2645
The Anteromedial Ultrasound Examination of the Large Supraaortic Vessels Identifies Higher Rates of Large Vessel Involvement Than Previous Reported in Patients with Giant Cell Arteritis
- Abstract Number: 2425
The anti-Ro52 Prevalence in the Sjögren’s Syndrome Picture: A Single Center Cross Sectional Study
- Abstract Number: 2657
The Association Between Bisphosphonates and Giant Cell Arteritis: A Retrospective Cohort Study
- Abstract Number: 2323
The Association Between Disease Activity with Coronary Microvascular Dysfunction in Rheumatoid Arthritis
- Abstract Number: 2501
The Association Between Metabolic Syndrome and Radiographic Damage in Psoriatic Arthritis
- Abstract Number: 2267
The Association Between Non-restorative Sleep and Diurnal Patterns of Cognitive Function and Fatigue in People with Fibromyalgia and Matched Controls
- Abstract Number: 2796
The Association Between Omega-3 Supplementation and Disease Activity in a Rheumatoid Arthritis (RA) Observational Cohort
- Abstract Number: 1121
The Association Between Physician Sex and Faculty Rank Among Academic Rheumatologists in the United States
- Abstract Number: 1388
The Association Between Treatment of Abatacept or Other Target Disease-Modifying Anti-rheumatic Drugs and Type 2 Diabetes Mellitus (T2DM)-Related Healthcare Resource Utilization and Costs in Commercially Insured Rheumatoid Arthritis Patients with T2DM
- Abstract Number: 1239
The Association Between Urate and CSF Markers of Alzheimer’s Disease in a Population-Based Sample of 70-Year-Olds
- Abstract Number: 1562
The Association of Body Weight Fluctuation and All-Cause Mortality in Patients with Systemic Lupus Erythematosus
- Abstract Number: 1851
The Association of Discrimination and Stress on Cardiovascular Disease in a Population-Based Cohort with Systemic Lupus Erythematosus
- Abstract Number: 1582
The Association of Lupus Nephritis Histopathologic Classification with Venous Thromboembolism Is Modified by Age at Biopsy
- Abstract Number: 2188
The Association of Plasma Fatty Acids Levels with Hand and Knee Osteoarthritis
- Abstract Number: 1681
The Association of Reduced Low-Density Lipoprotein (LDL) Cholesterol Levels with ANCA-Associated Vasculitis (AAV)
- Abstract Number: 878
The Association of Serum Magnesium with Chondrocalcinosis and Osteoarthritis
- Abstract Number: 2073
The Association of Serum Uric Acid Levels and the Risk of Lower Urinary Tract Symptoms in Korean Healthy Adults
- Abstract Number: 391
The Beneficial Effects of Rituximab Treatment in Myositis May Be Due to the Binding of a Non B-Cell Protein, SMPDL3B, in Skeletal Muscle
- Abstract Number: 179
The Burden of Comorbidity in Patients with RA, PSA or SPA in a General Practice Registry
- Abstract Number: 1773
The Card9-Neutrophil Signaling Axis Is Critical to Induction of Th17-Mediated Arthritis in SKG Mice
- Abstract Number: 2703
The Childhood Arthritis and Rheumatology Research Alliance Start Time Optimization of Biologic Therapy in Polyarticular JIA Study: Patient Characteristics, Patient Reported Outcomes and Consensus Treatment Plan Choices
- Abstract Number: 764
The Clinical and Angiographic Features of Chinese Takayasu’s Arteritis Patients: A Cohort Study of 591 Patients in 6 Years
- Abstract Number: 137
The Clinical and Laboratory Characteristics of Antiphospholipid Antibody Positive Patients Included in the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
- Abstract Number: 195
The Clinical Characteristics of Patients with Inflammatory Arthritis and a Persistently Low Alkaline Phosphatase Level in a Veteran Affairs Rheumatology Clinic
- Abstract Number: 1637
The Clinical Features of Anti-RNA Polymerase III Antibodypositive Systemic Sclerosis with and Without Malignancy
- Abstract Number: 1647
The Collaborative National Quality and Efficacy Registry for Scleroderma: Data Completion Outcomes from a Multicenter United States Cohort Using Guideline-Based Registry Practices
- Abstract Number: 148
The Combat Rheumatologist: Long Term Professional Outcomes of Graduates from a Tri-Service Military Rheumatology Fellowship Program
- Abstract Number: 2105
The Comparative Efficacy of Pneumocystis Pneumonia Prophylactic Regimens in Patients with Connective Tissue Diseases Receiving Prolonged High-dose Glucocorticoids
- Abstract Number: 1333
The Comparative Risk of Osteoporotic Fractures Among Patients with Rheumatoid Arthritis Receiving TNF Inhibitors versus Other Biologics: A Nation-wide Cohort Study in Korea
- Abstract Number: 1844
The Contribution of Disease Activity, Depression, and Anxiety to Health-Related and Non-Health-Related Quality of Life in US and Filipino Patients with SLE
- Abstract Number: 2596
The Contribution of Left Heart Disease in Patients with Systemic Sclerosis-associated Pulmonary Hypertension Having Normal Pulmonary Artery Wedge Pressure
- Abstract Number: 556
The Correlation of Bone Bridge and Low Bone Mineral Density Measured by Quantitative Computed Tomography in Patients with Ankylosing Spondylitis
- Abstract Number: 2299
The Course of Disability in Early Rheumatoid Arthritis over 10 Years of Follow-up in Women and Men – Comparison with the General Population
- Abstract Number: 449
The Course of Disability Related to Function of the Upper Extremities in Early Rheumatoid Arthritis over 10 Years of Follow-up
- Abstract Number: 2638
The Cumulative Burden of Damage for Patients with Eosinophilic Granulomatosis with Polyangiitis
- Abstract Number: 2060
The Current State of Big Data Use and Artificial Intelligence in RMDs: A Systematic Literature Review Informing EULAR Recommendations
- Abstract Number: 2490
The Cutaneous Microbiome of Psoriatic Disease Is Influenced by Disease Susceptibility HLA Alleles but Not Clinical Phenotype
- Abstract Number: 1777
The Deubiquitinase TRABID Is a Potential Therapeutic Target in Spondyloarthritis
- Abstract Number: 1124
The Direct and Indirect Costs of Illness Associated with Systemic Lupus Erythematosus in the USA, UK, France, and Germany: A Structured Review
- Abstract Number: 1060
The Diversity and Community Metrics of the Esophageal Microbiome of SSc Patients
- Abstract Number: 105
The DLEU2/miR-15a/16-1 Cluster Inhibit Foxp3+ Treg Cells in Salivary Glands of pSS via Targeting Foxp3
- Abstract Number: 2722
The down Syndrome Arthropathy Cohort in the New Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: Clinical Characteristics, Treatment and Outcomes
- Abstract Number: 500
The Dysregulation of NK Cells and Non-Conventional NK-T and γδ-T Cells in Individuals at Risk of Developing Rheumatoid Arthritis
- Abstract Number: 868
The Effect of Atorvastatin on Microvascular Endothelial Function and Raynaud Phenomenon in Early Diffuse Scleroderma: Results of the “Tamer”‘ Study
- Abstract Number: 2400
The Effect of Co-medication with Methotrexate and Other Conventional Synthetic Disease Modifying Anti-rheumatic Drugs on First Tumor Necrosis Inhibitor Drug Survival in Patients with Rheumatoid Arthritis: Results Form a Nationwide Registry
- Abstract Number: 2367
The Effect of DMARDs on Cardiovascular Outcomes in Rheumatoid Arthritis: A Systematic Literature Review
- Abstract Number: 13
The Effect of Estrogen and Interferon γ on the Immunobiology of Minor Salivary Gland Mesenchymal Stromal Cells
- Abstract Number: 1424
The Effect of HLA-DRB1 Risk Alleles (Shared Epitope) on Changes in Immune Cell Subsets and Disease Activity Following Treatment with Abatacept versus Adalimumab in Seropositive Biologic-Naïve Patients with Early, Moderate-to-Severe RA: Data from a Head-to-Head Single-Blinded Trial
- Abstract Number: 1046
The Effect of Nintedanib versus Mycopheolate Mofetil in the FRA2 Mouse Model of Systemic Sclerosis Associated Interstitial Lung Disease
- Abstract Number: 2890
The Effect of Rheumatoid Arthritis and Biologics on the Acquisition of Subsequent Diseases and Adverse Events: A Matched Longitudinal Population Study
- Abstract Number: 1502
The Effect of Tofacitinib on Residual Pain in Patients with Psoriatic Arthritis
- Abstract Number: 2392
The Effectiveness of anti-IL-6 Therapy to Elderly-onset Rheumatoid Arthritis
- Abstract Number: 242
The Effectiveness of Medications for Fibromyalgia Based on Patient Experiences
- Abstract Number: 902
The Effects of a Low-Fat, Mediterranean, or Low-Carbohydrate Diet on Serum Urate
- Abstract Number: 1615
The Effects of Anti-glutamate Receptor Subunit Antiantibodies on Systemic Lupus Erythematosus Without Neuropsychiatric Involvement
- Abstract Number: 1538
The Effects of Apremilast Therapy on Deployability in Active Duty U.S. Army Soldiers with Plaque Psoriasis and Psoriatic Arthritis
- Abstract Number: 459
The Effects of Erythrocytes and Platelets on Disease Activity in Patients with RA – ANSWER Longitudinal Cohort Study –
- Abstract Number: 2925
The Effects of Leisure Time Sitting and Sitting at Work on Worsening Radiographic Knee Osteoarthritis over Two Years: Data from the Osteoarthritis Initiative
- Abstract Number: 2265
The Effects of Message Framing on Patients’ Perceptions and Willingness to Switch to a Biosimilar
- Abstract Number: 1214
The Effects of Pegloticase on Mean Arterial Blood Pressure: An Age Modulated Relationship?
- Abstract Number: 914
The Effects of Vitamin D and Marine Omega-3 Fatty Acid Supplementation on Chronic Knee Pain in Older U.S. Adults
- Abstract Number: 1529
The Efficacy and Safety of Anti-TNFα Treatment in Ankylosing Spondylitis Patients with Late Onset Compared to Those with Adult Onset; The Data from TURKBIO Registry
- Abstract Number: 1382
The Efficacy of Low Dose Prednisone for Remission Induction in Newly Diagnosed Rheumatoid Arthritis Patients
- Abstract Number: 830
The Efficacy of Non-Pharmacological Interventions for Fibromyalgia: A Systematic Review with Meta-Analysis
- Abstract Number: 1943
The Emerging Regulatory Function of microRNA146a in Bone Biology and Osteoporosis
- Abstract Number: 462
The Endogenous Plasma Small RNAome of Rheumatoid Arthritis
- Abstract Number: 176
The Epidemiology of Rheumatoid Arthritis in the Czech Republic
- Abstract Number: 1790
The Epidemiology of the Antiphospholipid Syndrome in the UK, 1990 – 2016
- Abstract Number: 1936
The Expression of the Interferon Inducible Gene SERPING1 Is Reduced by Rituximab and Correlates with Clinical Response in Systemic Lupus Erythematosus
- Abstract Number: 2838
The First Phase 2a Proof-of-Concept Study of a Selective NLRP3 Inflammasome Inhibitor, Dapansutrile™ (OLT1177™), in Acute Gout
- Abstract Number: 499
The Generation of Anti-CCP Tests Affects Diagnostic Accuracy in Rheumatoid Arthiritis: A Systematic Literature Review and Meta-Analysis
- Abstract Number: 1787
The Glucocorticoid-Induced Protein GILZ Represent a Checkpoint in the IFN Program in SLE
- Abstract Number: 588
The Gut Enthesis Axis Coming into Focus with the Description of Enriched Entheseal Resident Mucosal Associated Invariant T-cells (MAITs) Capable of IL17A and TNF Production
- Abstract Number: 2081
The Health-promoting Potential of Everyday Activities: Preliminary Results from an Exploratory Study of Adults with and Without Inflammatory Arthritis
- Abstract Number: 2091
The High Dose Influenza Vaccine Increases Immune Protection in Both Adults and Elderly Seropositive RA Patients
- Abstract Number: 422
The Impact of Adalimumab vs Placebo on Patient-Reported Outcomes and Utility Measures Among Patients with Moderately to Severely Active Psoriatic Arthritis
- Abstract Number: 1251
The Impact of Aging on Familial Mediterranean Fever Patients
- Abstract Number: 43
The Impact of Air Pollution on Extracellular Vesicles as a Potential Pro-inflammatory Stimulus in Rheumatoid Arthritis
- Abstract Number: 1599
The Impact of Body Mass Index Variability in Systemic Lupus Erythematosus
- Abstract Number: 1621
The Impact of Disease Activity and Related Factors on Cognitive Dysfunction in SLE
- Abstract Number: 1151
The Impact of Gender on Time to Rheumatoid Arthritis Classification
- Abstract Number: 2507
The Impact of Psoriasis Severity on Outcomes Among Psoriatic Arthritis Patients Receiving Adalimumab
- Abstract Number: 956
The Impact of Psychiatric Comorbidity on Health Care Utilization and Preventive Health Care in Rheumatoid Arthritis: A Population Based Study
- Abstract Number: 1075
The Impact of Race on Birth Outcomes Among Women with Autoimmune Rheumatic Diseases
- Abstract Number: 563
The Impact of Sex and Disease Classification on Patient-reported Outcome Measures in Axial Spondyloarthritis: A Descriptive Prospective Cross-sectional Study
- Abstract Number: 156
The Impact of Spaced Education and Reciprocal Peer Teaching on Rheumatology Fellows’ Long-term Recall from Core Curriculum
- Abstract Number: 1577
The Impact of the New American College of Cardiology/American Heart Association Definition of Hypertension on Cardiovascular Events in Systemic Lupus Erythematosus
- Abstract Number: 1484
The Impact of Time Since First Diagnosis on the Efficacy and Safety of Tofacitinib in Patients with Active Psoriatic Arthritis
- Abstract Number: 523
The Impact of Upadacitinib versus Methotrexate or Adalimumab on Individual and Composite Disease Measures in Patients with Rheumatoid Arthritis
- Abstract Number: 188
The Importance of Diagnosis: Clinical Distinctions Between Adult JIA and RA, and a Characterization of Patients with JIA Reclassified as RA in Adulthood
- Abstract Number: 374
The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases: Subgroup with Autoimmune Diseases
- Abstract Number: 1456
The Increased Ratio of Blood CD56bright to CD56dim NK Cells Is a Distinguishing Feature of Primary Sjögren’s Syndrome
- Abstract Number: 117
The Indole Derivative NecroX Blocks Th17 Cell Differentiation and Fibroblast-like Synoviocytes-mediated Th1/Th17 Responses in Rheumatoid Arthritis
- Abstract Number: 478
The Influence of Gender on Composite Disease Activity Indices for Rheumatoid Arthritis
- Abstract Number: 458
The Influence of Mediterranean Diet in Rheumatoid Arthritis: A Monocenter Cross-sectional Study
- Abstract Number: 1017
The Integration of Genetic Data, Molecular Pathway Analysis and Differential Expression to Delineate the Impact of Ancestral Differences on Lupus
- Abstract Number: 2308
The Interaction Between Human Leukocyte Antigen Class II Alleles and Seroprotection to Seasonal Influenza Vaccination in Patients with Rheumatoid Arthritis: A post-hoc Analysis
- Abstract Number: 2811
The IRE1α Pathway Mediates Neutrophil Stress and NETosis in Lupus
- Abstract Number: 779
The Juvenile Idiopathic Arthritis-Associated IL2RA Haplotype Contains an Intronic Enhancer Whose Function Is Diminished by JIA-Associated Genetic Variants
- Abstract Number: 816
The Long Non-coding RNA HOTAIR Regulates BMP2 and Wnt Pathways in Synovial Fibroblasts
- Abstract Number: 819
The Long Noncoding RNA HOTTIP Regulates Cell Cycle and Inflammatory Response in Hand Synovial Fibroblasts
- Abstract Number: 1690
The Long-term Outcome of Patients with Arthritis of Behçet’s Disease
- Abstract Number: 722
The Lymphangiogenetic Factor VEGF-C and Its Receptor VEGFR-3 Are Associated with Pulmonary Arterial Hypertension in Systemic Sclerosis
- Abstract Number: 1948
The Mechanism of DC-STAMP-Mediated Signaling in Cell-Cell Fusion and Osteoclast Maturation
- Abstract Number: 1043
The Metabolic Intermediate Alpha-Ketoglutarate Suppresses the TGFβ-driven Profibrotic Responses of Dermal Fibroblasts
- Abstract Number: 737
The MUC5B Promoter Variant Does Not Predict Outcomes in Systemic Sclerosis-related Interstitial Lung Disease
- Abstract Number: 2792
The Need for Personalized, Non-Pharmacological Intervention Programmes in Autoimmune Connective Tissue Disorders: Results of a EULAR-Funded Scoping Review with a Nested, Descriptive Meta-Analysis
- Abstract Number: 1327
The Novel, Intra-articular CLK/DYRK1A Inhibitor Lorecivivint (LOR; SM04690), Which Modulates the Wnt Pathway, Improved Responder Outcomes in Subjects with Knee Osteoarthritis: A Post Hoc Analysis from a Phase 2b Trial
- Abstract Number: 2076
The Opioid Epidemic: The Rheumatology Response to Management of Chronic Pain
- Abstract Number: 1464
The Oral Microbiome as a Risk Factor for Benign or Pathologic Autoimmunity Associated with Anti-SSA/Ro Positivity and Mimicry for Von Willebrand Factor Type a Domain Protein (vWFA) of L. Mirabilis
- Abstract Number: 1949
The p.R321C Mutation in P62 Associated with Paget’s Disease of Bone Leads to a Change of Localization of the Protein in Human Osteoclasts
- Abstract Number: 2450
The Paradoxical Effect of Depression on Psoriatic Arthritis Outcomes in a Combined Psoriasis-Psoriatic Arthritis Center
- Abstract Number: 1785
The Pathogenic Potential of Choroid Plexus T Cells in Neuropsychiatric Lupus
- Abstract Number: 1328
The Patient’s Perspective on a Disease Flare During Tapering of DMARDs in Rheumatoid Arthritis
- Abstract Number: 2853
The Pattern of Musculoskeletal Complaints in Patients with Suspected Psoriatic Arthritis and Their Correlation with Physical Examination and Ultrasound
- Abstract Number: 1533
The Performance Characteristics of Composite Measures Used in a Randomized Trial Examining Etanercept and Methotrexate as Monotherapy or in Combination in Patients with Psoriatic Arthritis
- Abstract Number: 2452
The Performance of a Multi-marker Genetic Test to Identify Patients with Psoriatic Arthritis Among Psoriasis Patients
- Abstract Number: 696
The Performance of a Renal Activity Index in Lupus Nephritis in Induction Therapy
- Abstract Number: 2427
The Positivity for Anti-centromere Antibody Makes Distinct Clinical Features in Primary Sjogren’s Syndrome : Data from a Prospective Korean Nation-wide Cohort
- Abstract Number: 1052
The PPAR Agonist Lanifibranor Protects Against Right Ventricular Hypertrophy in a Mouse Model of Systemic Sclerosis Associated Pulmonary Hypertension
- Abstract Number: PP10
The Practice of Reiki and Meditation in Maintaining Medical Compliance and Decreased Anxiety in an Adult with Juvenile Rheumatoid Arthritis
- Abstract Number: 1938
The Pre-pregnancy Rheumatoid Arthritis Gene Expression Signature Correlates with Improvement or Worsening of Disease Activity During Pregnancy: A Pilot Study
- Abstract Number: 2769
The Pre-Treatment Gut Microbiome Predicts Early Response to Methotrexate in Rheumatoid Arthritis
- Abstract Number: 2762
The Preparation and Recovery Experience from Total Knee Replacement of Patients with Osteoarthritis: A Qualitative Study
- Abstract Number: 962
The Presence of Circulating CD19+CD21lo cells Predicts the Presence of Interstitial Lung Disease in Patients with Systemic Sclerosis
- Abstract Number: 893
The Presence of Extractable Nuclear Antigens (ENA) Antibodies in a Large Population-based Cohort from the Netherlands and Their Association with Known Risk Factors for Systemic Lupus Erythematosus and Primary Sjögren Syndrome
- Abstract Number: 1263
The Prevalence and Patterns of Celiac Disease Associated Arthropathy and Coexistence of Celiac Disease with Rheumatic Disorders in a Single Tertiary Medical Center
- Abstract Number: 2071
The Prevalence of 78 Autoimmune Diseases in Catalonia (MASCAT-PADRIS Big Data Project)
- Abstract Number: 667
The PROMIS-29 as a Measure of Type 1 and 2 SLE Activity
- Abstract Number: 1761
The Prospective Open Label Preventive Approach to Congenital Heart Block with Hydroxychloroquine (PATCH) Study Demonstrates a Reduction in the Recurrence Rate of Advanced Block
- Abstract Number: 1974
The Rat Homolog to FX201, a Gene Therapy in Development for the Treatment of Osteoarthritis, Demonstrates Dose-Dependent Decreases in the Severity of Cartilage and Bone Lesions Following Anterior Cruciate Ligament Transection
- Abstract Number: 1879
The Relation of Pain Sensitization and Conditioned Pain Modulation to Pain Patterns in Knee Osteoarthritis: The Multicenter Osteoarthritis Study
- Abstract Number: 1392
The Relationship Between Abatacept Exposure and CD86 Receptor Occupancy in Rheumatoid Arthritis Patients Following Subcutaneous Administration and Its Association to Patient Outcomes
- Abstract Number: 2442
The Relationship Between Fatigue and Disease Activity as Determined by Different Indices in Patients with Psoriatic Arthritis (PsA)
- Abstract Number: 735
The Relationship Between Gastrointestinal Symptoms and Severity and Whole Gut Transit in Patients with Systemic Sclerosis
- Abstract Number: 2732
The Relationship Between Gout and Cardiovascular Disease Outcomes: A Health Data Linkage Study of 1 Million New Zealanders Using Population-level Cardiovascular Risk Prediction Equations
- Abstract Number: 197
The Relationship Between Pain and Patient Demographics, Clinical Features, and Health Outcomes in a Cohort of Rheumatoid Arthritis Patients Recruited and Studied Using a Mobile Application
- Abstract Number: 1172
The Relationship Between Subclinical Inflammation and Bone Damage in Patients with Rheumatoid Arthritis Using Multimodality Imaging
- Abstract Number: 1145
The Representation of Skin Tones in Images of Patients with Lupus Erythematosus
- Abstract Number: 1130
The Risk of Toxic Retinopathy Among Patients on Hydroxychloroquine
- Abstract Number: 823
The Risk of Venous Thromboembolism in Patients with Psoriatic Disease and Rheumatoid Arthritis, a Population-based Study
- Abstract Number: 334
The Role of a ‘Treat-to-Target’ Approach on Long-term Renal Outcomes in Patients with Gout
- Abstract Number: 80
The Role of Adopter Protein SH3BP2 in a Murine Systemic Lupus Erythematosus Model
- Abstract Number: 2896
The Role of Alterations in the Splicing Machinery in the Pathogenesis of Lupus: Does It Impact Lupus Nephritis?
- Abstract Number: 2858
The Role of Bradykinin Receptor B1 and Its New Ligand Soluble CD13 in Rheumatoid Arthritis and Inflammatory Arthritis Mouse Model
- Abstract Number: 996
The Role of Flip in Differentiation and Survival of Synovial Tissue Resident Macrophages
- Abstract Number: 1095
The Role of Immunosuppressive Therapy in the Development of Atherosclerotic Cardiovascular Disease in Patients with Psoriatic Arthritis
- Abstract Number: 34
The Role of NFAT5-p65 Complex Enhanceosome in the Inflammatory Responses of Rheumatoid Arthritis Synovial Fibroblasts via TLR4 Signaling
- Abstract Number: 63
The Role of the Intestinal Microbiota in Lupus Nephritis
- Abstract Number: 2472
The Role of Ultrasound for the Assessment of Psoriatic Arthritis Patients with Fibromyalgia – Interim Analysis
- Abstract Number: 1099
The Safety of Pulse Therapy- Systematic Review and Meta-analysis
- Abstract Number: 2407
The Safety Profile of Upadacitinib in Japanese Patients with Rheumatoid Arthritis
- Abstract Number: 2436
The Salivary Glands as the Key Site of Inflammation and Lymphoproliferation Leading to Lymphoma in Primary Sjögren’s Syndrome: Relevance for Dedicated Scoring, Biomarker Development and Lymphoma Prevention
- Abstract Number: 239
The SELENA SLEDAI Is an Imperfect Measure of Lupus Disease Activity in Patients with Concomitant Fibromyalgia
- Abstract Number: 72
The Single-cell Transcriptomic Landscape of NZB/W Murine Lupus at Early and Late Stages of Disease
- Abstract Number: 1140
The Socioeconomic, Gender, Urban-rural, and Regional Disparities in the Risk of Acute Myocardial Infarction Among RA Patients
- Abstract Number: 2155
The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3-Year-Prospective Study from a Referral Center of Lung Transplantation
- Abstract Number: 1155
The Status of Latin-American Women in Rheumatology
- Abstract Number: 1260
The Study of Peripheral Blood Lymphocyte Subsets and CD4+T Subsets in Recurrent Polychondritis
- Abstract Number: 772
The Study of the Novel G87V Mutation in the TNFRSF1A Gene Identified in a Family with TNF Receptor-Associated Periodic Syndrome (TRAPS)
- Abstract Number: 1977
The Synthesis of Hydrogen Sulfide Is Impaired in Osteoarthritic Chondrocytes from Diabetic Patients and in Vitro in Cells Under High Glucose Environment
- Abstract Number: 1604
The Systemic Lupus Erythematosus Cardiovascular Risk Equation
- Abstract Number: 1261
The Time Lag – the Race in Diagnosis and Management of Hemophagocytic Lymphohistiocytosis
- Abstract Number: 2284
The Titer of Anti-Double Stranded DNA Antibody Could Affect the Apgar Score of Newborns, Which Is Considered as the Predictive Clinical Index for Neurological or Physical Development
- Abstract Number: 2819
The Transcription Factor MAF Controls the Ability of T Peripheral Helper (Tph) Cells to Help B Cells
- Abstract Number: 111
The Transcription Factor STAT3 Regulates Pathogenic Th17 Responses in Autoimmune Disease via Noncanonical Roles
- Abstract Number: 2254
The Urge for Mobile Apps in Rheumatology – a German Patient Perspective
- Abstract Number: 1093
The US Prevalence of Inflammatory Bowel Disease and Associated Axial Pain: Data from the National Health & Nutrition Examination Survey (NHANES)
- Abstract Number: 2902
The Use and Safety of Rituximab in Connective Tissue Disease Associated Interstitial Lung Disease
- Abstract Number: 621
The Use of Microbial Flow Cytometry to Analyze the Intestinal and Oral Microbiota
- Abstract Number: 1854
The Utility of Fat Lesions in Close Relation to Other Structural MRI Lesions in the Sacroiliac Joints for Diagnosing Patients with Axial Spondyloarthritis
- Abstract Number: 2281
The Vasculitis Pregnancy Registry (V-PREG): Information from the First 3 Years
- Abstract Number: 2656
The Veterans Health Administration (VHA) National Database Cohort: Incident Ophthalmic Complications in Giant Cell Arteritis (GCA) Patients with a Negative Temporal Artery Biopsy
- Abstract Number: 29
Therapeutic Anti-TNF Biologic Agents Exhibit Functional Differences in Blocking TNF-induced Effects on Human Monocytes In Vitro
- Abstract Number: 2135
Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features
- Abstract Number: 1146
Therapy of Lupus Nephritis with Mycophenolate Mofetil in Routine Clinical Practice: Response Rates and Role of Ethnicity
- Abstract Number: 285
Thermal Imaging in Rheumatoid Arthritis: A Comparative Analysis with Ultrasonography and Clinical Joint Assessment
- Abstract Number: 487
Third Generation Anti-cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Second Generation Anti-cyclic Citrullinated Peptide Positive Subjects at Risk of Rheumatoid Arthritis
- Abstract Number: 86
THOR-809: An IL-2 Engineered from an Expanded Genetic Alphabet for the Potential Treatment of Autoimmune Disorders
- Abstract Number: 1042
Thy-1 (CD90) as a Novel Marker for Tracking in Vivo Skin Fibrosis
- Abstract Number: 2432
Thymic Stromal Lymphopoietin (TSLP) as a Biomarker of Primary Sjögren’s Syndrome (pSS) and Related Lymphoma: Results in Independent Cohorts
- Abstract Number: 2129
Thyroperoxidase Antibodies in Patients with Positive ANA
- Abstract Number: 1821
Tildrakizumab Efficacy for Psoriatic Arthritis: 24-week Analysis of Swollen and Tender Joint Counts and Pain
- Abstract Number: 1524
Tildrakizumab Efficacy on Psoriasis in Patients with Psoriatic Arthritis—An Analysis from a Phase 2 Study
- Abstract Number: 1798
Time to Bridge the Gap in Rheumatology Education: Interactive Team Based Learning Is Most Effective in Increasing Internal Medicine Residents’ Knowledge
- Abstract Number: 1428
Time to Discontinuation of Tofacitinib in Rheumatoid Arthritis Patients with and Without Methotrexate: Results from a Rheumatoid Arthritis Cohort
- Abstract Number: 1838
Time to Flare in Patients with New-Onset versus Relapsing Giant Cell Arteritis Treated with Tocilizumab or Placebo Plus Prednisone Tapering: 3-Year Results from a Randomized Controlled Phase 3 Trial
- Abstract Number: 2518
Time to Lupus Low Disease Activity State: Role of African-American Ethnicity
- Abstract Number: 426
Time to Response for Clinical and Patient-Reported Outcomes in Patients with Psoriatic Arthritis Treated with Tofacitinib, Adalimumab, or Placebo
- Abstract Number: 2047
Time-trends in Opioid Use Hospitalizations in Common Musculoskeletal Conditions: Gout, Osteoarthritis, Rheumatoid Arthritis, Fibromyalgia, and Low Back Pain
- Abstract Number: 312
Timely Glucocorticoid Tapering in Vasculitis: A Need for Improved Knowledge Translation to Limit Toxicity
- Abstract Number: 885
TLR9 Signaling in HCV-Associated Atypical Memory B Cells Triggers Th1 and Rheumatoid Factor Autoantibody Responses
- Abstract Number: 947
TNF Inhibitor Treatment and Dramatic Stroke Risk Reduction in Patients with Deficiency of Adenosine Deaminase 2
- Abstract Number: 1003
TNF Inhibitors Improves Arterial Stiffness with Cs DMARDs-resistant Active Psoriatic Arthritis: A Cohort Extended Study
- Abstract Number: 938
TNF Inhibitors Reduce Spinal Radiographic Progression in Axial Spondyloarthritis by Mechanisms Associated with but Also Independent of Disease Activity
- Abstract Number: 809
TNF-α Drives Progressive Obliterative Pulmonary Vascular Disease and Represents a Novel Model of Connective-Tissue Disease Associated Pulmonary Arterial Hypertension (CTD-PAH)
- Abstract Number: 1167
To Evaluate Spine Ankylosis, Vertebral Fractures and Bone Fragility on a Single Imaging Exam in Patients with Ankylosing Spondylitis: Myth or Reality?
- Abstract Number: 1244
Tocilizumab – An Effective Rescue Therapy for Refractory Unclassified Autoinflammatory Diseases in Children
- Abstract Number: L10
Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
- Abstract Number: 1181
Tocilizumab in Aortitis: A Multicenter Study of 79 Patients
- Abstract Number: 2679
Tocilizumab in Giant Cell Arteritis: Route of Administration: Intravenous or Subcutaneous
- Abstract Number: 2681
Tocilizumab in Giant Cell Arteritis: The Safest and Most Effective Initial Dose of Prednisone
- Abstract Number: L14
Tofacitinib as Monotherapy Following Methotrexate Withdrawal in Patients with Psoriatic Arthritis Previously Treated with Open-label Tofacitinib + Methotrexate: A Randomized, Placebo-controlled Sub-study of OPAL Balance
- Abstract Number: 986
Tofacitinib Enhanced Cerebral Brain-derived Neurotrophic Factor Levelsin a Rat Model of Rheumatoid Arthritis
- Abstract Number: L22
Tofacitinib for the Treatment of Polyarticular Course Juvenile Idiopathic Arthritis: Results of a Phase 3 Randomized, Double-blind, Placebo-controlled Withdrawal Study
- Abstract Number: 863
Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis— Results of Phase I/II Investigator-Initiated, Double-Blind Randomized Placebo-Controlled Trial
- Abstract Number: 1444
Tofacitinib in Patients with Rheumatoid Arthritis and Indicative of Depression And/or Anxiety: A Post Hoc Analysis of Phase 3 and Phase 3b/4 Clinical Trials
- Abstract Number: 2418
Tofacitinib Inhibits Increased Inflammatory Marker Expression in a Human Salivary Cell Line Deficient in Autophagy: A Model of Sjögren’s Syndrome
- Abstract Number: 544
Tolerance, Survival, and Adherence to Methotrexate Treatment in Patients with Rheumatoid Arthritis
- Abstract Number: 2085
Too Soon to Say: Promising Results from a Community-Delivered RCT Examining Work-Related Outcomes of the Chronic Disease Self-Management Program
- Abstract Number: 2742
Toward a Liquid Biopsy for Lupus Nephritis: Urine Proteomic Analysis of SLE Identifies Inflammatory and Macrophage Signatures
- Abstract Number: 2322
Toward Cardiovascular Risk Stratification in Rheumatoid Arthritis: Use of Regression Tree Analyses to Evaluate Impact of Serum Biomarkers and Cardiovascular Risk Factors on Carotid Intima Media Thickness
- Abstract Number: 49
Towards a Single Cell Portrait of Rheumatoid Arthritis – Development of a Single Cell Multiomics Pipeline for Phase 2 of the Accelerating Medicine Partnership (AMP) – RA Network
- Abstract Number: 2770
Towards the Lowest Efficacious Dose (ToLEDo): Results of a Multicenter Non-Inferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis Patients in Remission
- Abstract Number: 2601
Trabecular Bone Score and Malnutrition in a Cohort of Systemic Sclerosis Patients
- Abstract Number: 1738
Tracking Whole-Brain Volumetric Trends in Childhood-onset Systemic Lupus Erythematosus Patients in the Clinical Setting by Magnetic Resonance Imaging
- Abstract Number: 2798
Trajectories of Opioid Filling Patterns After Total Knee Replacement
- Abstract Number: 840
Trajectory of Multimorbidity in Rheumatoid Arthritis in a U.S. Commercial Insurance Claims Database from 2006-2015
- Abstract Number: 17
Transcription Factor Fli-1 Impacts Lupus Nephritis by Orchestrating CXCL10/CXCR3 Axis
- Abstract Number: 2899
Transcriptomic Meta-analysis of Lupus Affected Tissues Reveals Shared Immune, Metabolic, and Biochemical Dysregulation
- Abstract Number: 1951
Transcriptomic Responses in CD4+ T Cells During Successful Therapy for Juvenile Idiopathic Arthritis
- Abstract Number: 2078
Transitions in Lumbar Spine Osteoarthritis: The Johnston County Osteoarthritis Project
- Abstract Number: 988
Translational Imaging of Treatment Effects for a Novel Anti-TNF-Steroid Antibody Drug Conjugate in a Rat Model of Rheumatoid Arthritis
- Abstract Number: 2389
Treat to Target by Specific Cytokine Interdiction: Multiple Biomarker Disease Activity Test Deconstructed
- Abstract Number: 2337
Treat to Target Is Not Linked to Best Myocardial Strain Indices: Is There Really a Myocardial Dysfunction Directly Associated with Disease Activity?
- Abstract Number: 1862
Treat to Target Opportunities – Design, Testing, and Adoption of a Novel EHR-Integrated Electronic System to Engage Rheumatologists and Capture Decision Making
- Abstract Number: 414
Treat-to-Target Approach in the Management of Elderly Rheumatoid Arthritis Patients
- Abstract Number: 336
Treating Gout to Target Entails Renoprotective Effect in Patients with Moderate Chronic Kidney Disease
- Abstract Number: 388
Treating Statin-induced Anti-HMGCR Myopathy with Normal Muscle Strength: A New Window of Opportunity
- Abstract Number: 2830
Treatment Delays Associated with Prior Authorization for Infusible Medications: A Cohort Study
- Abstract Number: 763
Treatment Efficacy Evaluation of Leflunomide by Regulating Macrophages in Takayasu Arteritis
- Abstract Number: 2383
Treatment for Rheumatoid Arthritis After Methotrexate-associated Lymphoproliferative Disorder Developed
- Abstract Number: 2340
Treatment of Interstitial Lung Disease and Airway Disease Complicated with Rheumatoid Arthritis
- Abstract Number: 941
Treatment of Lupus Nephritis with anti-CD20 Followed by Anti-BAFF: Impact on B Cell Reconstitution, B Cell Subsets, and Autoreactivity
- Abstract Number: 69
Treatment of Lupus-prone MRL-lpr Mice with the Mitochondrial Antioxidant MitoQ
- Abstract Number: 2520
Treatment of SLE Patients with the Immunoproteasome Inhibitor KZR-616: Results from the First 3 Cohorts of an Open-Label Phase 1b Dose Escalation Trial
- Abstract Number: 953
Treatment Patterns and Persistency Following the First Biologic DMARD in Patients with Rheumatoid Arthritis: Real-World Analysis of 2012–2016 US Medicare Data
- Abstract Number: 2369
Treatment Patterns with Disease Modifying Anti-rheumatic Drugs in United States Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis
- Abstract Number: 2691
Treatment Patterns, Disease Burden and Outcomes in Patients with Giant Cell Arteritis and Polymyalgia Rheumatica
- Abstract Number: 250
Treatment Patterns, Dose Change, and Treatment Discontinuation in RA Patients Switching from First Biologic DMARD to Another Treatment in the US
- Abstract Number: 2266
Treatment Preferences in Patients with Axial Spondyloarthritis
- Abstract Number: 2791
Treatment Response Criteria for Anti-neutrophil Cytoplasmic Antibodies (ANCA)-vasculitis: Results of a Scoping Review
- Abstract Number: 1389
Treatment Response to Biologic DMARDs in Patients with RA: A Retrospective Analysis of the RISE Registry
- Abstract Number: 252
Treatment Sequences, Effectiveness, and Costs of Tumor Necrosis Factor Inhibitor Cycling Compared with Swapping to a Novel Disease-modifying Anti-rheumatic Drug in Rheumatoid Arthritis Patients
- Abstract Number: 124
Treatment with Abatacept but Not with TNF Blockers, Is Associated with a Reduction of Constitutively Elevated Circulating Follicular Helper T Cells in Rheumatoid Arthritis
- Abstract Number: 2343
Treatment with Biologic DMARDs Does Not Increase Risk of Severe Pulmonary Events in Patients with Rheumatoid Arthritis and Pre-existing Lung Disease
- Abstract Number: 1237
Treatment with OLT1177™, an Oral NLRP3 Inflammasome Inhibitor, Reduces Systemic Inflammation During Gout Flares in Humans
- Abstract Number: 510
Treatment with Upadacitinib Is Associated with Improvements in Reverse Cholesterol Transport in Patients with Rheumatoid Arthritis: Correlation with Changes in Inflammation and HDL Levels
- Abstract Number: 522
Treatment with Upadacitinib Results in the Normalization of Key Pathobiologic Pathways in Patients with Rheumatoid Arthritis
- Abstract Number: 1404
Treatments Patterns Among Patients with Rheumatoid Arthritis Treated with a Biologic Disease-modifying Anti-rheumatic Drug: A Nation-wide Study in Korea
- Abstract Number: 821
Trends in Incidence and Prevalence of Osteoarthritis in the United Kingdom: Findings from the Clinical Practice Research Datalink (CPRD)
- Abstract Number: 1097
Trends in NSAIDs and Opioids Among Patients with SLE: A Population-based Study
- Abstract Number: 2202
Trends in Prescribing of NSAIDs and Opioids Among Osteoarthritis Patients in British Columbia, Canada, 1998-2014
- Abstract Number: 1934
Tripartite Motif (TRIM) Gene Family Expression in Dermatomyositis
- Abstract Number: 2097
Tuberculin Skin Test and Quantiferon®-TB Gold In-Tube Test for Latent Tuberculosis Before Biologic Treatments: Lower Agreement Rate in Spondyloarthropathies Compared to Rheumatoid Arthritis
- Abstract Number: 1917
Tubulointerstitial Inflammation Predicts Outcomes in Lupus Nephritis
- Abstract Number: 1335
Tumor Necrosis Factor Alpha Inhibitor (TNF-α Inhibitor) Exposure and Risk of Hip Fracture in Veterans with Rheumatoid Arthritis: A Nested Case Control Study
- Abstract Number: 933
Tumor Necrosis Factor Inhibitors Slow Radiologic Progression in Patients with Ankylosing Spondylitis: 18-year Longitudinal Cohort Study
- Abstract Number: 94
Tumor Necrosis Factor Receptor 2 Signaling Potentiates Proliferation and Suppressive Activities of Follicular Regulatory T Cells
- Abstract Number: 1933
Tumorigenesis Related Gene Identification in Dermatomyositis Using Meta-Analysis
- Abstract Number: 1518
Tumour Necrosis Factor Inhibitor Monotherapy versus Combination Therapy with Conventional Synthetic Disease-modifying Anti-rheumatic Drugs for the Treatment of Psoriatic Arthritis: A Combined Analysis of European Biologics Databases
- Abstract Number: 1944
Two Biomarkers with Predictive Capacity to Diagnosis Pre-Radiographic Knee Osteoarthritis: Data from the Osteoarthritis Initiative
- Abstract Number: 2373
Two Decades of Changes in RA Treatment and Disease Outcomes from the United States
- Abstract Number: 853
Two-Year Progression of Facet Joint Ankylosis on Whole Spine Low-Dose CT in Patients with Radiographic Axial Spondyloarthritis
- Abstract Number: 1019
Type I Interferon Levels Vary with Regional Ancestry in European-derived SLE Cohorts
- Abstract Number: 788
Type I Interferon Score and Interferon Induced Mediators CXCL10 and Neopterin Are Correlated with Disease Activity in Juvenile Dermatomyositis
- Abstract Number: 88
Type I Interferon Signature Activation in Antiphospholipid Syndrome: Gene Expression Heterogeneity Among Disease Subsets
2019 ACR/ARP Annual Meeting
November 8-13, 2019 in Atlanta, GA